Financials
- Market Capitalization 477.32 M
- Employee 116
- Founded 2013
- CEO Shankar Musunuri
- Website www.ocugen.com
- Headquarter Delaware, United States
- FIGI BBG00194VJB1
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2935 | NVCT Nuvectis Pharma, Inc. - Common Stock | 18.44 USD | +0.49% | -6.73% | +68.56% | +120.31% | 489.13 M USD | ||
| 2938 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.61 USD | -8.52% | -21.08% | -3.01% | -22.60% | 486.32 M USD | ||
| 2960 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 7.77 USD | -8.48% | -14.99% | -5.47% | +75.79% | 472.38 M USD | ||
| 2961 | VSTM Verastem, Inc. - Common Stock | 5.37 USD | -2.89% | +19.60% | +29.09% | +7.83% | 471.88 M USD |
Frequently asked questions about Ocugen, Inc. - Common Stock
What is the Ocugen, Inc. - Common Stock stock price today?
The current price of Ocugen, Inc. - Common Stock (OCGN) is 1.41. Over the past 24 hours, the stock has changed by -4.08%. Follow the OCGN chart for real-time price dynamics.
What is the stock ticker of Ocugen, Inc. - Common Stock?
Ocugen, Inc. - Common Stock trades under the ticker OCGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ocugen, Inc. - Common Stock stock going up?
OCGN has changed by -6.62% over the last week, +11.02% over the last month, and +25.89% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Ocugen, Inc. - Common Stock net income for the last quarter?
Ocugen, Inc. - Common Stock reported net income of -19.18 M for the last quarter. The previous quarter showed -17.71 M, which means net income changed by -8.31%.
How many employees does Ocugen, Inc. - Common Stock have?
As of the latest available data, Ocugen, Inc. - Common Stock has 116 employees. Workforce size can provide additional context about the company's scale and operations.
What is Ocugen, Inc. - Common Stock EBITDA?
Ocugen, Inc. - Common Stock EBITDA is -16.27 M, and its EBITDA margin is -1 061.45%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Ocugen, Inc. - Common Stock stock?
You can buy Ocugen, Inc. - Common Stock (OCGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ocugen, Inc. - Common Stock stock?
Investing in Ocugen, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the OCGN chart and related analysis on metatrader.com as part of your research.